Jiudian Pharmaceutical (300705.SZ) released its 2023 annual performance report. The company achieved operating income during the reporting period...
According to Zhitong Finance App, Jiudian Pharmaceutical (300705.SZ) released its 2023 annual results report. During the reporting period, the company achieved operating income of 2,693 billion yuan, an increase of 15.75%; net profit attributable to shareholders of listed companies was 368 million yuan, an increase of 36.54% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 340 million yuan, an increase of 36.91% year on year; basic earnings per share were 1.07 yuan.